Cargando…

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System

BACKGROUND: The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription factor that is able to modulate the expression of many target genes and influence a variety of cellular pathways. Inactivation of the p53 pathway in cancer frequently occurs through the expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreotti, Virginia, Ciribilli, Yari, Monti, Paola, Bisio, Alessandra, Lion, Mattia, Jordan, Jennifer, Fronza, Gilberto, Menichini, Paola, Resnick, Michael A., Inga, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107237/ https://www.ncbi.nlm.nih.gov/pubmed/21674059 http://dx.doi.org/10.1371/journal.pone.0020643

Ejemplares similares

Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
por: Ciribilli, Yari, et al.
Publicado: (2013)

ΔN-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites
por: Monti, Paola, et al.
Publicado: (2014)

P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements
por: Raimondi, Ivan, et al.
Publicado: (2013)

Evolution of p53 Transactivation Specificity through the Lens of a Yeast-Based Functional Assay
por: Lion, Mattia, et al.
Publicado: (2015)

Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay
por: Sharma, Vasundhara, et al.
Publicado: (2015)

Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay
por: Monti, Paola, et al.
Publicado: (2021)

Whole-genome cartography of p53 response elements ranked on transactivation potential
por: Tebaldi, Toma, et al.
Publicado: (2015)

P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development
por: Monti, Paola, et al.
Publicado: (2019)

Cooperative interactions between p53 and NFκB enhance cell plasticity
por: Bisio, Alessandra, et al.
Publicado: (2014)

The Coordinated P53 and Estrogen Receptor Cis-Regulation at an FLT1 Promoter SNP Is Specific to Genotoxic Stress and Estrogenic Compound
por: Ciribilli, Yari, et al.
Publicado: (2010)

Mutant p53(K120R) expression enables a partial capacity to modulate metabolism
por: Monti, Paola, et al.
Publicado: (2022)

Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival
por: Foggetti, Giorgia, et al.
Publicado: (2019)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear
por: Monti, Paola, et al.
Publicado: (2017)

Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Identification of new p53 target microRNAs by bioinformatics and functional analysis
por: Bisio, Alessandra, et al.
Publicado: (2013)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Correction: Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Antitumor Effects of PRIMA-1 and PRIMA-1(Met) (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
por: Menichini, Paola, et al.
Publicado: (2021)

In silico identification and functional validation of allele-dependent AR enhancers
por: Garritano, Sonia, et al.
Publicado: (2015)

Transactivation by low and high levels of human p53 reveals new physical rules of engagement and novel super-transactivation sequences
por: Menendez, Daniel, et al.
Publicado: (2012)

The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor Recruitment
por: Parrini, Matthias, et al.
Publicado: (2018)

The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
por: Fregni, Matilde, et al.
Publicado: (2022)

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study
por: De Luca, Giuseppa, et al.
Publicado: (2022)

Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
por: Marengo, Barbara, et al.
Publicado: (2018)

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
por: Monti, Paola, et al.
Publicado: (2020)

ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells()
por: Alessandrini, Federica, et al.
Publicado: (2018)

c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma
por: Ciribilli, Yari, et al.
Publicado: (2016)

The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
por: Biatta, Chiara M., et al.
Publicado: (2023)

The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms
por: Porubiaková, Otília, et al.
Publicado: (2019)

Regression based predictor for p53 transactivation
por: Gowrisankar, Sivakumar, et al.
Publicado: (2009)

Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas
por: Ciribilli, Yari, et al.
Publicado: (2015)

Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells
por: Menendez, Daniel, et al.
Publicado: (2013)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma
por: Ciribilli, Yari, et al.
Publicado: (2017)

Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma
por: Ciribilli, Yari, et al.
Publicado: (2018)

ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis
por: Meškytė, Erna Marija, et al.
Publicado: (2023)

Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development
por: Bruno, William, et al.
Publicado: (2017)

Gentian violet induces wtp53 transactivation in cancer cells
por: GARUFI, ALESSIA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gf8v18bhvu4e5oaittfasttj4h